Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Lexicon Pharmaceutcl (LXRX)

Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin) GlobeNewswire - Fri Dec 20, 3:30PM CST

LXRX : 0.7147 (-1.23%)
Author
2 Generic Drug Stocks Ready to Surge in 2025 MarketBeat - Wed Nov 27, 7:30AM CST

Explore how Teva Pharmaceuticals and Viatris are leading the generics industry with strong growth, robust pipelines, and strategies for 2025 success.

LXRX : 0.7147 (-1.23%)
VTRS : 12.52 (+3.22%)
TEVA : 22.09 (+3.66%)
AMGN : 263.38 (+0.84%)
PFE : 26.36 (+2.29%)
Lexicon Pharmaceuticals Completes Patient Enrollment for PROGRESS Study of LX9211, Exceeding Targets by 20% Quiver Quantitative, Inc. - Tue Nov 26, 5:20PM CST

Lexicon Pharmaceuticals exceeded enrollment targets in its PROGRESS study of LX9211 for diabetic peripheral neuropathic pain, aiming for Q1 2025 data.Quiver AI SummaryLexicon Pharmaceuticals announced...

LXRX : 0.7147 (-1.23%)
Lexicon Announces Completion of Enrollment in Phase 2B PROGRESS Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP) GlobeNewswire - Tue Nov 26, 7:00AM CST

LXRX : 0.7147 (-1.23%)
Lexicon Pharmaceuticals to Participate in December Investor Conferences GlobeNewswire - Mon Nov 25, 3:15PM CST

LXRX : 0.7147 (-1.23%)
Lexicon Pharmaceuticals Announces Strategic Restructuring to Focus on R&D and Cut Operating Costs by $100 Million Quiver Quantitative, Inc. - Fri Nov 22, 4:48PM CST

Lexicon Pharmaceuticals is restructuring to eliminate commercial operations, focusing on R&D, expecting $100 million in cost savings by 2025.Quiver AI SummaryLexicon Pharmaceuticals, Inc. has announced...

LXRX : 0.7147 (-1.23%)
Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA GlobeNewswire - Fri Nov 22, 6:32AM CST

LXRX : 0.7147 (-1.23%)
Ivan H. Cheung Elected to Board of Directors of Lexicon Pharmaceuticals, Inc. Quiver Quantitative, Inc. - Thu Nov 21, 1:20AM CST

Lexicon Pharmaceuticals announces Ivan H. Cheung’s election to its Board of Directors, highlighting his extensive biopharmaceutical experience.Quiver AI SummaryLexicon Pharmaceuticals, Inc. has announced...

LXRX : 0.7147 (-1.23%)
Lexicon Appoints Ivan H. Cheung to Board of Directors GlobeNewswire - Wed Nov 20, 3:05PM CST

LXRX : 0.7147 (-1.23%)
Post-Hoc Analysis Demonstrating Sotagliflozin Benefits Across Broad Spectrum of Heart Failure Patient Populations is Among Four Lexicon-Supported Presentations at the American Heart Association’s (AHA) Sessions 2024 in Chicago GlobeNewswire - Thu Nov 14, 7:00AM CST

LXRX : 0.7147 (-1.23%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot